BIMI International Medical Receives Nasdaq Notification Of Non-Compliance With Listing Rule 5250(c)(1)
Portfolio Pulse from Benzinga Newsdesk
BIMI International Medical has received a notification from Nasdaq about its non-compliance with Listing Rule 5250(c)(1).
August 24, 2023 | 1:27 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BIMI International Medical has been notified by Nasdaq about its non-compliance with Listing Rule 5250(c)(1). This could potentially lead to delisting if not rectified.
Non-compliance with Nasdaq's listing rules can lead to delisting, which would significantly impact the company's stock price and its ability to raise capital. This news is highly relevant and important for BIMI's investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100